tradingkey.logo

Stryker Corp

SYK
查看詳細走勢圖
352.135USD
-1.955-0.55%
交易中 美東報價延遲15分鐘
134.66B總市值
45.70本益比TTM

Stryker Corp

352.135
-1.955-0.55%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.55%

5天

-3.26%

1月

-2.78%

6月

-6.67%

今年開始到現在

-2.20%

1年

-6.00%

查看詳細走勢圖

TradingKey Stryker Corp股票評分

單位: USD 更新時間: 2025-12-12

操作建議

Stryker Corp當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名40/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價429.60。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Stryker Corp評分

相關信息

行業排名
40 / 208
全市場排名
117 / 4592
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 32 分析師
買入
評級
429.597
目標均價
+21.49%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Stryker Corp亮點

亮點風險
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
業績高增長
公司營業收入穩步增長,連續3年增長22.47%
利潤高增長
公司淨利潤處於行業前列,最新年度總收入22.59B美元
高分紅
公司屬於高分紅公司,最新股息支付率41.30%
穩定分紅
公司5年內持續分紅,最新股息支付率41.30%
估值合理
公司最新PE估值45.96,處於3年歷史合理位
機構減倉
最新機構持股311.59M股,環比減少1.82%
HACAX持倉
明星投資者HACAX持倉,最新持倉4.91K股

Stryker Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Stryker Corp簡介

Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
公司代碼SYK
公司Stryker Corp
CEOLobo (Kevin A)
網址https://www.stryker.com/

常見問題

Stryker Corp(SYK)的當前股價是多少?

Stryker Corp(SYK)的當前股價是 352.135。

Stryker Corp 的股票代碼是什麼?

Stryker Corp的股票代碼是SYK。

Stryker Corp股票的52週最高點是多少?

Stryker Corp股票的52週最高點是406.190。

Stryker Corp股票的52週最低點是多少?

Stryker Corp股票的52週最低點是329.161。

Stryker Corp的市值是多少?

Stryker Corp的市值是134.66B。

Stryker Corp的淨利潤是多少?

Stryker Corp的淨利潤為2.99B。

現在Stryker Corp(SYK)的股票是買入、持有還是賣出?

根據分析師評級,Stryker Corp(SYK)的總體評級為買入,目標價格為429.597。

Stryker Corp(SYK)股票的每股收益(EPS TTM)是多少

Stryker Corp(SYK)股票的每股收益(EPS TTM)是7.705。
KeyAI